Loading…
Mesa Laboratories, Inc. is projected to rise to $111.88 by 2027, a +23% move from its current price of $90.80. MLAB is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $87.87 | $90.77 | $93.76 | -0.04% |
| May 30 | $86.66 | $90.73 | $94.99 | -0.07% |
| May 31 | $85.74 | $90.70 | $95.94 | -0.11% |
| Jun 1 | $84.97 | $90.66 | $96.75 | -0.15% |
| Jun 2 | $84.29 | $90.63 | $97.45 | -0.19% |
| Jun 3 | $83.67 | $90.60 | $98.09 | -0.22% |
| Jun 4 | $83.11 | $90.56 | $98.68 | -0.26% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $83.11 | $90.56 | $98.68 | -0.26% |
| Week 2 | $80.00 | $90.33 | $101.99 | -0.52% |
| Week 3 | $77.64 | $90.09 | $104.54 | -0.78% |
| Week 4 | $75.67 | $89.85 | $106.69 | -1.04% |
| Week 5 | $73.96 | $89.62 | $108.59 | -1.30% |
| Week 6 | $72.43 | $89.39 | $110.31 | -1.56% |
| Week 7 | $71.03 | $89.15 | $111.89 | -1.81% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Mesa Laboratories, Inc. develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries.
This segment also provides testing and laboratory services to the dental and pharmaceutical industries.
Its Clinical Genomics segment offers MassARRAY, a genetic analysis tool system, and related consumables, including chips, panels, and chemical reagent solutions used by clinical labs to analyze DNA samples for inherited genetic disease testing, pharmacogenetics, oncology testing, infectious disease testing, doping and toxicology testing, and other differentiated applications for use in research. The Biopharmaceutical Development segment provides automated systems, such as Gyrolab xPand and Gyrolab xPlore hardware and software, Gyrolab Bioaffy consumable microfluidic disks, Gyrolab kits and Rexxip buffers for protein analysis; PurePep Chorus and Symphony instruments for peptide synthesis; and PurePep EasyClean products for purifying peptides.
Its Calibration Solutions segment offers quality control products to measure and calibrate critical parameters in applications, such as environmental and process monitoring, dialysis, gas flow, air quality, and torque testing in medical device and pharmaceutical manufacturing, laboratory, and hospital environments. This segment's products include continuous monitoring systems, dialysate meters and consumables, data loggers, gas flow calibration and air sampling equipment, and torque testing systems under DialyGuard, ViewPoint, DataTrace, DryCal, and BGI brands. Mesa Laboratories, Inc.
was incorporated in 1982 and is headquartered in Lakewood, Colorado.
Mesa Laboratories, Inc. (MLAB) is a producer of life sciences tools and quality control products, with a current price of $90.80 and a market cap of $501.65M. The stock ranks 3016.
The near-term outlook shows upside potential as the 2026 forecast calls for an average price of $90.80 with a 0% ROI, and a 30-day range of $73.31 to $112.46 alongside a max of $120.11. The multi-year forecast points to meaningful upside beyond 2026, with bullish sentiment beginning in 2027 and compounding through 2050, culminating in a 2050 average price of $891.71 and an ROI of 882.1%.
A major floor 19.4% below — a decisive break under it would weaken the trend.
Price is testing support right now (0.0% away) — a key level to hold.
The nearest ceiling, 20.2% above — a clean break opens room to run.
A major ceiling 26.9% above — clearing it would confirm fresh momentum.
Key MLAB support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of MLAB market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $103.74 | Sell | $100.79 | Sell |
| MA 10 | $101.76 | Sell | $101.88 | Sell |
| MA 20 | $102.34 | Sell | $101.47 | Sell |
| MA 50 | $96.09 | Sell | $97.57 | Sell |
| MA 100 | $91.52 | Sell | $92.78 | Sell |
| MA 200 | $82.08 | Buy | $90.82 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 38.26 | Neutral |
| Stoch RSI (14) | 0.00 | Buy |
| CCI (20) | -231.03 | Sell |
| Williams %R (14) | -100.00 | Info |
| MACD (12,26,9) | -0.84 | Sell |
| ROC (12) | -13.23 | Sell |
| Bollinger %B (20,2) | -0.17 | Buy |
| Stochastic %K (14) | 0.00 | Buy |
| TRIX (15) | 0.30 | Buy |
| Awesome (5,34) | 2.75 | Buy |
| Ultimate (7,14,28) | 39.68 | Neutral |
| Momentum (10) | -12.89 | Sell |
| Aroon Osc (25) | -12.00 | Sell |
| Hull MA (9) | 104.70 | Sell |
| ADX (14) | 19.00 | Neutral |
| ATR (14) | 3.22 | Info |
The 30-day technical picture shows bullish momentum in the near term, with RSI(14) at 40 and the stock trading above the 200-day trend while the SMA50 is $96.09 and the SMA200 is $82.08. Near-term support is at $90.80 and resistance at $109.11. The 30-day price range spans from $73.31 to $112.46, highlighting upside potential beyond the current level.
Annualized volatility sits around 60%, indicative of elevated price variability.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $73.23 | $90.80 | $120.11 | 0% | Neutral | |
| $87.11 | $111.88 | $153.15 | +23% | Bullish | |
| $100.86 | $133.88 | $191.00 | +47% | Bullish | |
| $125.38 | $171.11 | $252.17 | +88% | Bullish | |
| $140.31 | $196.28 | $297.29 | +116% | Bullish | |
| $128.97 | $184.56 | $286.30 | +103% | Bullish | |
| $140.20 | $204.94 | $324.80 | +126% | Bullish | |
| $155.91 | $232.51 | $375.72 | +156% | Bullish | |
| $176.43 | $268.20 | $441.19 | +195% | Bullish | |
| $217.65 | $337.00 | $563.61 | +271% | Bullish | |
| $267.21 | $450.23 | $806.81 | +396% | Bullish | |
| $455.74 | $891.71 | $1,765.92 | +882% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $73.23 | $90.80 | $107.19 | +0.00% |
| June 2026 | $77.16 | $90.99 | $110.12 | +0.20% |
| July 2026 | $73.68 | $87.76 | $107.91 | -3.55% |
| August 2026 | $74.19 | $89.07 | $110.86 | +1.49% |
| September 2026 | $76.89 | $92.91 | $116.79 | +4.32% |
| October 2026 | $75.75 | $92.08 | $116.79 | -0.89% |
| November 2026 | $73.97 | $90.40 | $115.56 | -1.82% |
| December 2026 | $75.94 | $93.27 | $120.11 | +3.17% |
Click any year to see its month-by-month MLAB forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, MLAB could reach as high as $120.11, with a base case around $90.80 and support toward $73.23 — roughly 0% from $90.80. A consolidation phase looks the most probable path here.
Expect MLAB to range from $87.11 to $153.15 through 2027. The $111.88 average target implies a +23% move from current prices. That is up +23% on the projected 2026 average. Momentum favours further upside here.
The MLAB price prediction for 2028 points to an average of $133.88 (low $100.86, high $191.00) — a potential gain of +47% on today's $90.80. Buyers look set to stay in control over this stretch.
In 2029, MLAB is projected to trade between $125.38 and $252.17, averaging $171.11 — a potential gain of +88% from today's $90.80. That is up +28% on the projected 2028 average. Momentum favours further upside here.
Mesa Laboratories, Inc.'s 2030 outlook centres on $196.28, within a $140.31 to $297.29 range. That is up +15% on the projected 2029 average. That marks a +116% change versus current levels. Buyers look set to stay in control over this stretch.
By 2031, MLAB could reach as high as $286.30, with a base case around $184.56 and support toward $128.97 — roughly +103% from $90.80. Momentum favours further upside here.
Expect MLAB to range from $140.20 to $324.80 through 2032. The $204.94 average target implies a +126% move from current prices. That is up +11% on the projected 2031 average. Buyers look set to stay in control over this stretch.
The MLAB price prediction for 2033 points to an average of $232.51 (low $155.91, high $375.72) — a potential gain of +156% on today's $90.80. Momentum favours further upside here.
In 2034, MLAB is projected to trade between $176.43 and $441.19, averaging $268.20 — a potential gain of +195% from today's $90.80. That is up +15% on the projected 2033 average. Buyers look set to stay in control over this stretch.
Mesa Laboratories, Inc.'s 2035 outlook centres on $337.00, within a $217.65 to $563.61 range. That is up +26% on the projected 2034 average. That marks a +271% change versus current levels. Momentum favours further upside here.
By 2040, MLAB could reach as high as $806.81, with a base case around $450.23 and support toward $267.21 — roughly +396% from $90.80. Buyers look set to stay in control over this stretch.
Expect MLAB to range from $455.74 to $1,765.92 through 2050. The $891.71 average target implies a +882% move from current prices. That is up +98% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in MLAB today (≈ 11.013216 MLAB) could be worth
$9,820.62
+$8,820.62 (+882%) by 2050 · US Dollar
Based on the average projected MLAB price of $891.71 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in MLABwould be worth at today's price.
$1,000 invested in MLAB on May 27, 2025 (≈ 8.833922 MLAB) would be worth
$802.12
-$197.88 (-19.8%) today · 0.80× · US Dollar
Based on a MLAB entry price of $113.2 vs. today's $90.8.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $104 | $873.08 | -12.7% |
| 1 month ago | $98.28 | $923.89 | -7.6% |
| 3 months ago | $95.56 | $950.19 | -5.0% |
| 6 months ago | $80.2 | $1,132.17 | +13.2% |
| 1 year ago | $113.2 | $802.12 | -19.8% |
| All time (5.0y) ago | $253.67 | $357.95 | -64.2% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our MLAB forecast.
Our base-case forecast reaches $180.00 around 2030.
Implied market cap at $180.00: $994.47M
The multi-year forecast envisions a strong uptrend with the 2030 average price of $196.28 and a 116.2% ROI. The 2040 forecast shows an average price of $450.23 and a 395.9% ROI, while the 2050 forecast projects an average price of $891.71 and an 882.1% ROI. Early years project steady gains: 2027 avg $111.88, 2028 $133.88, 2029 $171.11, with continued growth through 2035 at $337.00 and beyond.
The overall outlook remains bullish through 2050, though these figures are estimates and not guarantees, subject to market and sector risks.
Tap a question to reveal the answer.
avg $196.28, min $140.31, max $297.29, ROI 116.2%, sentiment BULLISH.
Forecasts show bullish sentiment from 2027 onward with rising averages and positive ROI through 2050 (2030 avg $196.28 ROI 116.2%, 2050 avg $891.71 ROI 882.1%).
In 2026, max is $120.11; longer horizon shows higher levels, including 2034 max $441.19 and 2050 max $1,765.92.
Low $73.31, high $112.46.
Current price $90.80.
Mesa Laboratories, Inc. Community Discussion
0Share your Mesa Laboratories, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.